The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
Delineation of the genomic complexities of malignant pleural mesothelioma (MPM) has lagged behind other malignancies. Zhang et al. meaningfully add to our understanding of MPM, and their findings emphasize the need to combine drug development efforts with appropriate predictive biomarkers.
Guardado en:
Autor principal: | Marjorie G. Zauderer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8049a635b45f44a6ac1f11106fa5999b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytomegalovirus infection in malignant pleural mesothelioma.
por: DeVon Hunter-Schlichting, et al.
Publicado: (2021) -
Modern management of malignant pleural mesothelioma
por: Patel SC, et al.
Publicado: (2016) -
Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi M, et al.
Publicado: (2017) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Sara Ricciardi, et al.
Publicado: (2021) -
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma
por: Masayuki Watanabe, et al.
Publicado: (2021)